BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 27567691)

  • 1. Linking resistin, inflammation, and cardiometabolic diseases.
    Park HK; Kwak MK; Kim HJ; Ahima RS
    Korean J Intern Med; 2017 Mar; 32(2):239-247. PubMed ID: 28192887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells.
    Robichaud S; Fairman G; Vijithakumar V; Mak E; Cook DP; Pelletier AR; Huard S; Vanderhyden BC; Figeys D; Lavallée-Adam M; Baetz K; Ouimet M
    Autophagy; 2021 Nov; 17(11):3671-3689. PubMed ID: 33590792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A missense variant in human perilipin 2 (
    Scorletti E; Saiman Y; Jeon S; Schneider CV; Buyco DG; Lin C; Himes BE; Mesaros CA; Vujkovic M; Creasy KT; Furth EE; Billheimer JT; Hand NJ; Kaplan DE; Chang KM; Tsao PS; Lynch JA; Dempsey JL; Harkin J; Bayen S; Conlon D; Guerraty M; Phillips MC; Rader DJ; Carr RM
    JHEP Rep; 2024 Jan; 6(1):100902. PubMed ID: 38074507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perilipin1 Expression as a Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung.
    Kim MH; Lee JH; Lee JS; Kim DC; Yang JW; An HJ; Na JM; Jung WJ; Song DH
    Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an obesogenic high-fat and high-sucrose diet on hepatic gene expression signatures in male Collaborative Cross mice.
    Tryndyak VP; Willett RA; Nagumalli SK; Li D; Avigan MI; Beland FA; Rusyn I; Pogribny IP
    Am J Physiol Gastrointest Liver Physiol; 2023 Mar; 324(3):G232-G243. PubMed ID: 36625475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy.
    Corvillo F; Abel BS; López-Lera A; Ceccarini G; Magno S; Santini F; Araújo-Vilar D; Brown RJ; Nozal P; López-Trascasa M
    Diabetes; 2023 Jan; 72(1):71-84. PubMed ID: 35771980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perilipins at a glance.
    Najt CP; Devarajan M; Mashek DG
    J Cell Sci; 2022 Mar; 135(5):. PubMed ID: 35260890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway.
    Lee J; Hong SW; Kim MJ; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
    Endocrinol Metab (Seoul); 2022 Feb; 37(1):74-83. PubMed ID: 35144334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway.
    Khalifa O; Al-Akl NS; Errafii K; Arredouani A
    Sci Rep; 2022 Feb; 12(1):2226. PubMed ID: 35140289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
    Mashek DG
    Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol effects on hepatic lipid metabolism.
    Jeon S; Carr R
    J Lipid Res; 2020 Apr; 61(4):470-479. PubMed ID: 32029510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Lipid Droplet Isolation Protocol Using a Well-established Organelle Isolation Kit.
    Brettschneider J; Correnti JM; Lin C; Williams B; Oranu A; Kuriakose A; McIver-Jenkins D; Haba A; Kaneza I; Jeon S; Scorletti E; Carr RM
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways of nonalcoholic fatty liver disease development and progression.
    Bessone F; Razori MV; Roma MG
    Cell Mol Life Sci; 2019 Jan; 76(1):99-128. PubMed ID: 30343320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis.
    Williams B; Correnti J; Oranu A; Lin A; Scott V; Annoh M; Beck J; Furth E; Mitchell V; Senkal CE; Obeid L; Carr RM
    FASEB J; 2018 Jan; 32(1):130-142. PubMed ID: 28864659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perilipin Staining Distinguishes Between Steatosis and Nonalcoholic Steatohepatitis in Adults and Children.
    Carr RM; Dhir R; Mahadev K; Comerford M; Chalasani NP; Ahima RS
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):145-147. PubMed ID: 27567691
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid Droplet-Associated Proteins Perilipin 1 and 2: Molecular Markers of Steatosis and Microvesicular Steatotic Foci in Chronic Hepatitis C.
    Schelbert S; Schindeldecker M; Drebber U; Witzel HR; Weinmann A; Dries V; Schirmacher P; Roth W; Straub BK
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features of hepatocellular carcinoma with fatty change: Tumors with macrovesicular steatosis have better prognosis and aberrant expression patterns of perilipin and adipophilin.
    Kubota N; Ojima H; Hatano M; Yamazaki K; Masugi Y; Tsujikawa H; Fujii-Nishimura Y; Ueno A; Kurebayashi Y; Shinoda M; Kitago M; Abe Y; Kitagawa Y; Sakamoto M
    Pathol Int; 2020 Apr; 70(4):199-209. PubMed ID: 31930673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perilipin discerns chronic from acute hepatocellular steatosis.
    Pawella LM; Hashani M; Eiteneuer E; Renner M; Bartenschlager R; Schirmacher P; Straub BK
    J Hepatol; 2014 Mar; 60(3):633-42. PubMed ID: 24269473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?
    Pattullo V; Douglas MW; George J
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):265-77. PubMed ID: 21476921
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.